Lymphoma development and survival in refractory coeliac disease type II: Histological response as prognostic factor

BACKGROUND: Refractory coeliac disease type II (RCDII) frequently transforms into an enteropathy-associated T-cell lymphoma (EATL) and therefore requires intensive treatment. Current evaluated treatment strategies for RCDII include cladribine (2-CdA) and autologous stem cell transplantation (auSCT)....

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:United European Gastroenterol J
Asıl Yazarlar: Nijeboer, P, van Wanrooij, RLJ, van Gils, T, Wierdsma, NJ, Tack, GJ, Witte, BI, Bontkes, HJ, Visser, O, Mulder, CJJ, Bouma, G
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2016
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5349358/
https://ncbi.nlm.nih.gov/pubmed/28344788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640616646529
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller